Autologous stem autologous transplant cord blood. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy37

Fetal Blood Stem Cells Spinal Cord Hematopoietic Stem Cells Transplants Umbilical Cord Cells, Cultured Autografts T-Lymphocytes Bone Marrow Cells Plant Stems Adult Stem Cells Mesenchymal Stromal Cells Neoplastic Stem Cells Bone Marrow Pluripotent Stem Cells Induced Pluripotent Stem Cells Leukocytes, Mononuclear T-Lymphocytes, Cytotoxic Neural Stem Cells Dendritic Cells Lymphocytes Multipotent Stem Cells Killer Cells, Natural Clone Cells CD4-Positive T-Lymphocytes Fetal Stem Cells Blood Cells B-Lymphocytes Brain Stem Monocytes Spermatic Cord Platelet-Rich Plasma Antilymphocyte Serum CD8-Positive T-Lymphocytes T-Lymphocytes, Regulatory Cell Line

Organisms5

Mice, SCID Mice, Inbred NOD Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus

Diseases47

Multiple Myeloma Hodgkin Disease Recurrence Spinal Cord Injuries Lymphoma, Non-Hodgkin Amyloidosis Lymphoma, Mantle-Cell Lymphoma, Follicular Hematologic Neoplasms Graft vs Host Disease Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, B-Cell Leukemia, Myeloid, Acute Neoplasm, Residual Postoperative Complications Acute Disease Leukemia, Myeloid Enteropathy-Associated T-Cell Lymphoma Leukemia, Plasma Cell Neoplasms, Second Primary Myelodysplastic Syndromes Cytomegalovirus Infections Leukemia Neuroblastoma Neoplasm Recurrence, Local Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Spinal Cord Diseases Mucositis Neutropenia Disease Progression Stomatitis Spinal Cord Compression Medulloblastoma Breast Neoplasms Disease Models, Animal Central Nervous System Neoplasms Melanoma Hematologic Diseases Thrombocytopenia Cadaver Spinal Cord Ischemia Spinal Cord Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, AIDS-Related

Chemicals and Drugs53

Melphalan Antigens, CD34 Etoposide Thiotepa Cyclophosphamide Carmustine Cytarabine Vincristine Myeloablative Agonists Immunosuppressive Agents Boronic Acids Dexamethasone Pyrazines Doxorubicin Thalidomide Antibodies, Monoclonal, Murine-Derived Granulocyte Colony-Stimulating Factor Busulfan Ifosfamide Antineoplastic Agents, Alkylating Prednisone Podophyllotoxin Antibodies, Monoclonal Mitoxantrone Antineoplastic Agents Antigens, CD Stem Cell Factor HLA Antigens Carboplatin Cyclosporine Idarubicin Tacrolimus Antigens, Neoplasm Immunoglobulin Light Chains Interleukin-2 Recombinant Proteins Keratins, Type II Cancer Vaccines Biological Markers Interferon-gamma Cisplatin Cytokines Nitrogen Mustard Compounds Myeloma Proteins Antilymphocyte Serum Mycophenolic Acid Immunologic Factors Granulocyte-Macrophage Colony-Stimulating Factor Antigens, CD45 Antigens, CD38 Prednisolone Immunoconjugates Antigens, CD20

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Treatment Outcome Blood Transfusion, Autologous Survival Analysis Retrospective Studies Combined Modality Therapy Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Remission Induction Salvage Therapy Kidney Transplantation Bone Marrow Purging Disease-Free Survival Survival Rate Whole-Body Irradiation Follow-Up Studies Prognosis Leukapheresis Cell Separation Mesenchymal Stem Cell Transplantation Flow Cytometry Heart Transplantation Immunophenotyping Prospective Studies Histocompatibility Testing Transplantation Blood Component Removal Induction Chemotherapy Lymphocyte Activation Feasibility Studies Lung Transplantation Cell Transplantation Lymphocyte Culture Test, Mixed Colony-Forming Units Assay Immunotherapy Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Immunosuppression Risk Factors Coculture Techniques Life Tables Fatal Outcome Fetal Tissue Transplantation Cell Culture Techniques Platelet Count Infusions, Spinal Radioimmunotherapy Immunomagnetic Separation Pilot Projects Leukocyte Count Drug Administration Schedule Immunotherapy, Adoptive Blood Cell Count Blood Preservation Kaplan-Meier Estimate Tissue Engineering Bone Transplantation Disease Models, Animal Transplantation, Heterologous Multivariate Analysis Clinical Trials as Topic Cell- and Tissue-Based Therapy Tissue Transplantation Blood Transfusion Treatment Failure Cohort Studies Transduction, Genetic Immunohistochemistry Cryopreservation Cytotoxicity Tests, Immunologic Cell Count Polymerase Chain Reaction Neoplasm Staging Transplantation, Isogeneic Predictive Value of Tests

Phenomena and Processes27

Graft Survival Time Factors Graft Rejection Cell Differentiation Hematopoiesis Pregnancy Lymphocyte Activation Cytotoxicity, Immunologic Cell Lineage Platelet Count Cell Proliferation Dose-Response Relationship, Drug Maternal-Fetal Exchange Stem Cell Niche Histocompatibility Leukocyte Count Blood Cell Count Transplantation Immunology Cell Division Regeneration Immunocompromised Host Phenotype Transduction, Genetic Cell Survival Cell Count Recovery of Function Genetic Vectors

Disciplines and Occupations2

Immunohistochemistry Regenerative Medicine

Technology, Industry, Agriculture1

Tissue Engineering

Information Science3

Survival Rate Life Tables Fatal Outcome

Named Groups3

Infant, Newborn Tissue Donors Living Donors

Health Care23

Treatment Outcome Survival Analysis Retrospective Studies Disease-Free Survival Survival Rate Blood Banks Follow-Up Studies Prospective Studies Feasibility Studies Risk Factors Life Tables Fatal Outcome Tissue and Organ Procurement Pilot Projects Kaplan-Meier Estimate Waiting Lists Directed Tissue Donation Multivariate Analysis Clinical Trials as Topic Treatment Failure Cohort Studies Age Factors Predictive Value of Tests

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Transplantation Conditioning Multiple Myeloma Stem Cell Transplantation Fetal Blood Hematopoietic Stem Cell Mobilization Hodgkin Disease Treatment Outcome Recurrence Stem Cells Melphalan Blood Transfusion, Autologous Spinal Cord Survival Analysis Retrospective Studies Combined Modality Therapy Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Hematopoietic Stem Cells Remission Induction Salvage Therapy Antigens, CD34 Spinal Cord Injuries Etoposide Lymphoma, Non-Hodgkin Graft Survival Kidney Transplantation Bone Marrow Purging Thiotepa Disease-Free Survival Cyclophosphamide Carmustine Cytarabine Vincristine Survival Rate Myeloablative Agonists Transplants Time Factors Umbilical Cord Blood Banks Whole-Body Irradiation Amyloidosis Follow-Up Studies Immunosuppressive Agents Lymphoma, Mantle-Cell Graft Rejection Cells, Cultured Boronic Acids Dexamethasone Pyrazines Autografts Lymphoma, Follicular Hematologic Neoplasms Prognosis Doxorubicin Thalidomide Infant, Newborn Tissue Donors Graft vs Host Disease Lymphoma, T-Cell, Peripheral Antibodies, Monoclonal, Murine-Derived Granulocyte Colony-Stimulating Factor Busulfan Leukapheresis Ifosfamide T-Lymphocytes Cell Separation Antineoplastic Agents, Alkylating Bone Marrow Cells Lymphoma Mesenchymal Stem Cell Transplantation Prednisone Plant Stems Adult Stem Cells Flow Cytometry Podophyllotoxin Cell Differentiation Mesenchymal Stromal Cells Heart Transplantation Immunophenotyping Neoplastic Stem Cells Prospective Studies Histocompatibility Testing Transplantation Hematopoiesis Antibodies, Monoclonal Lymphoma, Large B-Cell, Diffuse Pregnancy Bone Marrow Lymphoma, B-Cell Blood Component Removal Induction Chemotherapy Lymphocyte Activation Feasibility Studies Lung Transplantation Mitoxantrone Leukemia, Myeloid, Acute

No FAQ available that match "autologous stem autologous transplant cord blood"